期刊文献+

血清tPSA、PSAD及Gleason评分在前列腺癌分期中的应用价值 被引量:21

Total PSA,PSA density and biopsy Gleason score in predicting the pathologic stage of prostate cancer
下载PDF
导出
摘要 目的:探讨血清前列腺特异性抗原(PSA)系列及穿刺组织活检Gleason评分在前列腺癌病理分期的预测价值。方法:回顾性分析我院1999~2008年病理证实为前列腺腺癌的124例患者资料,将该124例患者根据术后病理、骨扫描和CT或MRI结果分为A、B两组。骨扫描、CT、MRI或术后证实为有周围浸润或远处转移者归为A组;无周围浸润且无远处转移者归为B组。比较两组之间以上各指标的差异。通过多因素回归分析筛选前列腺癌病理分期的影响因子。运用工作特征曲线(ROC曲线)比较各指标的预测价值。结果:tPSA、穿刺活检Gleason评分值A组明显高于B组(P<0.05);多元Logistic回归分析中,仅tPSA进入模型,被认为是最主要的预测因子。ROC曲线对前列腺病理分期预测效力比较:联合分析tPSA与穿刺活检Gleason评分预测效果明显高于其他指标,工作特征曲线下面积(AUC)从大到小依次为Gleason评分+tPSA>tPSA>PSAD+tPSA+Gleason评分。结论:tPSA依然是临床上对前列腺癌病理分期较好的预测因素;联合穿刺组织活检Gleason评分,可以提高预测准确度,对指导临床治疗和预后有重要意义。 Objective:To evaluate the roles of total prostate specific antigen (tPSA),PSA density (PSAD) and biopsy Gleason score in predicting the pathologic stage of prostate cancer.Methods:We retrospectively analyzed the clinical data of 124 cases of pathologically confirmed prostate adenocarcinoma,and divided them into Groups A (n = 48) and B (n = 76) based on the results of bone scanning,CT,MRI,tPSA,PSAD and postoperative biopsy Gleason score,the former with extraprostatic infiltration or distant metastasis,while the latter without.We compared the above parameters between the two groups,screened the main factors that influenced the pathologic staging of prostate cancer by multivariate logistic regression analysis,and appraised the value of each of the para-meters in predicting the pathologic stage of prostate cancer with a relative operating characteristic (ROC) curve.Results:The tPSA level and biopsy Gleason score were significantly higher in Group A than in B (P0.05).Multivariate logistic regression analysis showed that only tPSA could predict the pathologic stage of localized prostate cancer.The ROC curve exhibited that the combined use of tPSA and Gleason score had a better predicting value than other parameters (Gleason score + tPSA tPSA PSAD + tPSA + Gleason score).Conclusion:Total PSA remains a valuable predictor of the pathologic stage of prostate cancer,and its combination with Gleason score can further improve the predictive accuracy and contribute much to the treatment and prognosis of the disease.
出处 《中华男科学杂志》 CAS CSCD 北大核心 2010年第5期415-419,共5页 National Journal of Andrology
基金 山东省2008年科学技术发展计划(2008GG30002009)~~
关键词 前列腺肿瘤 总前列腺特异性抗原 前列腺特异性抗原密度 GLEASON评分 病理分期 prostatic neoplasm total prostate specific antigen prostate specific antigen density Gleason score pathologic stage
  • 相关文献

参考文献13

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics,2007. CA Cancer J Clin, 2007, 57 ( 1 ) : 43..66.
  • 2Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA, 1997, 277 (18): 1445-1451.
  • 3Seaman EK, Whang IS, Cooner W, et al. Predictive value of prostate specific antigen density for the presence of mierometastatic carcinoma of the prostate. Urology, 1994, 43 (5) : 645-648.
  • 4Taneja SS, Hsu EI, Cheli CD, et al. Complexed prostate specific antigen as a staging tool: Results based on a muhicenter prospective evaluation of complexed prostate specific antigen in cancer diagnosis. Urology, 2002, 60( 4 Supp 1) : 10-17.
  • 5Horiguchi A, Nakashima J, Horiguchi Y,et al. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer. Prostate, 2003, 56( 1 ) : 23-29.
  • 6Shinohara K, Wolf JS Jr, Narayan P, et al. Comparison of prostate specific antigen with prostate specific antigen density for 3 cli-nical applications. J Urol, 1994, 152 (1) : 120-123.
  • 7Custovic Z, Kraus O, Tomaskovic I, et al. Serum tPSA, cPSA, related density parameters and chromogranin A as predictors of positive margins after radical prostatectomy. Anticancer Res, 2007, 27(4C) : 2817-2821.
  • 8Giannarini G, Scott CA, Moro U, et al. Are PSA density and PSA density of the transition zone more accurate than PSA in pre- dicting the pathological stage of clinically localized prostate cancer? Uro! Oncol, 2008, 26(4) : 353-360.
  • 9Poulakis V, Witzsch U, De Vries R, et al. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen, and Gleason score to predict prostate cancer stage. J Urol, 2004, 172(4 Pt 1) : 1306-1310.
  • 10钟晨阳,刘明,张力青,万奔.前列腺癌分期方法的临床评价[J].中华男科学杂志,2003,9(2):100-102. 被引量:2

二级参考文献9

  • 1[1]Amy VK, Gary DG, David MS, et al. Use of imaging tests for staging newly diagnosed prostate cancer: trends from the CaPSURE database[J]. J Urol, 1998, 160(12): 2102-2106.
  • 2[2]Gerard JO, Robert WV, Roberto O, et al. Update on the appropriate staging evaluation for newly diagnosed prostate cancer[J]. J Urol, 1997, 158(9): 687-698.
  • 3[3]Anthony VD, Richard W, Malkowicz SB, et al. Combination of the preoperative PSA level, biopsy Gleason score, predict early PSA failure in men with clinically localized prostate cancer[J]. Urology, 2000, 55(4): 572-577.
  • 4[4]Badalament RA, Miller MC, Peller PA, et al. An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level[J]. J Urol, 1996, 156(4): 1375-1380.
  • 5[5]Peller PA, Young DC, Marmaduke CD, et al. Sextant prostate biopsies A histopathologic correlation with radical prostatectomy specimens[J]. Cancer, 1995, 75(2): 530-538.
  • 6[6]Epstein JI, Partin AW, Potter SR, et al. Adenocarcinoma of the prostate invading the seminal vesicle: prognostic stratification based on pathologic parameters[J]. Urology, 2000,56(2):283-288.
  • 7马腾骧.现代泌尿外科学[M].天津科学技术出版社,2001..
  • 8周国强,丁明霞,周青莲,袁青.PSA及PSAD测定对前列腺癌的诊断价值[J].中华泌尿外科杂志,1998,19(9):537-540. 被引量:16
  • 9应俊,姚德鸿,任晓敏,袁素芬,张庆华.BPH病人血清FPSA/TPSA比值的临床应用[J].中华男科学杂志,2001,7(3):167-169. 被引量:12

共引文献14

同被引文献229

引证文献21

二级引证文献146

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部